Register
ECOG: Ibrutinib-based therapy is the most effective treatment for untreated CLL |
Journal Updates
eMediNexus Coverage from: 
ECOG: Ibrutinib-based therapy is the most effective treatment for untreated CLL
eMediNexus,  05 December 2018
remove_red_eye 539 Views
#Hematology #Oncology #Pathology and Lab Medicine

0 Read Comments                

The chemotherapy-free combination of ibrutinib + rituximab topped the most active chemo-immunotherapy regimen in newly diagnosed untreated chronic lymphocytic leukemia (CLL), as per findings of the phase III ECOG trial presented at the American Society of Hematology (ASH) meeting in San Diego.

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!